Windtree Therapeutics Targets $520 Million in Funding to Secure BNB Reserve

Windtree Therapeutics (WINT), a publicly listed biotechnology company, announced today that it has entered into two significant financial agreements to raise up to $520 million for the acquisition of BNB (BNB). Overall, the firm has earmarked nearly $700 million to buy BNB, the fifth-largest cryptocurrency by market capitalization. Windtree Commits $520 Million to Build a BNB Treasury According to a press release issued by Windtree on July 24, the company entered into an agreement to sell its common stock to raise up to $500 million. This will create an equity line of credit (ELOC) source: https://beincrypto.com/windtree-therapeutics-bnb-treasury/